CELECOXIB

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID3997
Ligand NameCELECOXIB
PubMed Compound Id2662
StructureProduct Image
Molecular FormulaC17H14F3N3O2S
Molecular Weight381.4
SMILESCC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
Synonymscelecoxib
169590-42-5
Celebra
Onsenal
Celecox
184007-95-2
Xilebao
YM177
YM 177
HSDB 7038
Celecoxibum
UNII-JCX84Q7J1L
DFN15
JCX84Q7J1L
NSC-719627
NSC-758624
ELYXYB
CCRIS 9330
DFN-15
DTXSID0022777
CHEBI:41423
DTXCID502777
CONSENSI COMPONENT CELECOXIB
NSC719627
NSC 719627
NSC 758624
CELECOXIB (MART.)
CELECOXIB [MART.]
CELECOXIB (USP-RS)
CELECOXIB [USP-RS]
CELECOXIB (EP MONOGRAPH)
CELECOXIB [EP MONOGRAPH]
CELECOXIB (USP MONOGRAPH)
CELECOXIB [USP MONOGRAPH]
Generic Drug
ELYXYB-celecoxib
Celecoxib 50 mg
Celecoxib 100 mg
Celecoxib 200 mg
Celecoxib 400 mg
L01XX33
M01AH01
CELECOXIB COMPONENT OF CONSENSI
Celebrex
Celocoxib
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
SC-58635
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
SC 58635
MFCD00941298
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
194044-54-7
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
SC58635
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
Celecoxib (GMP Like)
YM-177
CHEMBL118
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de
4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
Celecoxib [USAN]
NCGC00091455-01
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
Solexa
Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
Celebrex (TN)
SMR000550473
CAS-169590-42-5
SR-01000837528
Celecixib
Celecoxib [USAN:INN:BAN]
Celecoxib?
TPI-336
Celecoxib (GMP)
Onsenal (TN)
AI-525
CEP-33222
CELEBCOXIB
Celecoxib (Standard)
Spectrum_000432
1oq5
CELECOXIB [INN]
CELECOXIB [JAN]
CELECOXIB [MI]
CELECOXIB [HSDB]
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
CELECOXIB [VANDF]
CELECOXIB [WHO-DD]
cid_2662
SCHEMBL3708
BSPBio_003596
CELECOXIB [EMA EPAR]
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
MLS001165684
MLS001195656
MLS001304708
MLS006011862
BIDD:GT0408
DivK1c_000893
SPECTRUM1503678
Celecoxib - Bio-X trade mark
SPBio_001512
Celecoxib (JP18/USP/INN)
GTPL2892
CELECOXIB [ORANGE BOOK]
BDBM11639
HMS502M15
KBio1_000893
KBio2_000912
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
EX-A175
MSK8005
cMAP_000027
NINDS_000893
BCPP000290
GLXC-05108
HMS1922G14
HMS2089L18
HMS2093I07
HMS2234N18
HMS3259L08
HMS3261A14
HMS3373A09
HMS3654H09
HMS3715F11
HMS3867I03
HMS3884M07
HMS5079P03
HY-14398GL
Pharmakon1600-01503678
ALBB-033772
BCP02156
UWA68620
UWA68621
Tox21_111135
Tox21_201964
Tox21_300599
Tox21_500406
US8741944, Comparative Compound
4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
BBL029086
CCG-39354
HY-14398G
HY-14398R
NSC758624
s1261
STL373576
Celecoxib 1.0 mg/ml in Acetonitrile
AKOS015842517
Tox21_111135_1
AC-4228
BCP9000507
CS-0570
DB00482
FC11300
KS-1041
NC00708
SB19318
IDI1_000893
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCGC00091455-05
NCGC00091455-06
NCGC00091455-07
NCGC00091455-08
NCGC00091455-09
NCGC00091455-13
NCGC00254540-01
NCGC00259513-01
NCGC00261091-01
BC164295
BP-30217
HY-14398
NCI60_041049
PHA-00846533
SY064976
SBI-0051875.P002
CJ-016377
CP-598107
UNM-0000305813
C2816
CS-0901612
NS00002556
SW199611-3
PF-00345549
C07589
D00567
EN300-119504
AB00052396-07
AB00052396-08
AB00052396-09
AB00052396_10
AB00052396_11
Q408801
SR-01000837528-2
SR-01000837528-3
BRD-K02637541-001-02-4
BRD-K02637541-001-06-5
BRD-K02637541-001-17-2
BRD-K02637541-001-18-0
Z1258938406
Celecoxib, European Pharmacopoeia (EP) Reference Standard
Celecoxib, United States Pharmacopeia (USP) Reference Standard
4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide
4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide
5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole
Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyazol-1-yl]benezenesulfonamide
4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide;Celebra
4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamid e; Celebra;Celocoxib;SC 58635; SC-58635
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm